Related references
Note: Only part of the references are listed.B7-H3: An Attractive Target for Antibody-based Immunotherapy
Filippos Kontos et al.
CLINICAL CANCER RESEARCH (2021)
Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy
Wentao Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
M. Heider et al.
MOLECULAR CELL (2021)
Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Matthew A. Nix et al.
CANCER DISCOVERY (2021)
The therapeutic landscape for cells engineered with chimeric antigen receptors
Matthew MacKay et al.
NATURE BIOTECHNOLOGY (2020)
Ultrasound localization microscopy of renal tumor xenografts in chicken embryo is correlated to hypoxia
Matthew R. Lowerison et al.
SCIENTIFIC REPORTS (2020)
Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes
Kevin K. Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal
Tobias Baumann et al.
NATURE IMMUNOLOGY (2020)
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
Johanna Theruvath et al.
NATURE MEDICINE (2020)
Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer
Jeemin Yim et al.
EUROPEAN JOURNAL OF CANCER (2020)
A Quantitative Proteome Map of the Human Body
Lihua Jiang et al.
CELL (2020)
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
Meenakshi Hegde et al.
NATURE COMMUNICATIONS (2020)
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer
Juniper A. Scribner et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
B7-H3, a checkpoint molecule, as a target for cancer immunotherapy
Shuo Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Francesca Finotello et al.
GENOME MEDICINE (2019)
Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7
Wu Di et al.
CELL DEATH & DISEASE (2019)
Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells
Davide Ceresa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue
Yu Si et al.
SCIENCE IMMUNOLOGY (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma
Anna Gabrych et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
Giulia Bertolini et al.
BMC CANCER (2018)
B7-H3 in tumors: friend or foe for tumor immunity?
Gen Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis
Qinglian Tang et al.
ONCOGENE (2018)
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
John K. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins
Alexander J. Martinko et al.
ELIFE (2018)
New B7 Family Checkpoints in Human Cancers
Ling Ni et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma
Yong Mao et al.
ONCOLOGY LETTERS (2017)
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function
Young-hee Lee et al.
CELL RESEARCH (2017)
Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells
Ronghui Li et al.
MOLECULAR MEDICINE REPORTS (2016)
Transcriptomics resources of human tissues and organs
Mathias Uhlen et al.
MOLECULAR SYSTEMS BIOLOGY (2016)
Toxicity and management in CAR T-cell therapy
Challice L. Bonifant et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
freeQuant: A Mass Spectrometry Label-Free Quantification Software Tool for Complex Proteome Analysis
Ning Deng et al.
TheScientificWorldJOURNAL (2015)
freeQuant: A Mass Spectrometry Label-Free Quantification Software Tool for Complex Proteome Analysis
Ning Deng et al.
Scientific World Journal (2015)
A novel subset of B7-H3+CD14+HLA-DR-/low myeloid-derived suppressor cells are associated with progression of human NSCLC
Guangbo Zhang et al.
ONCOIMMUNOLOGY (2015)
Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression
Fu-Biao Kang et al.
ONCOLOGY REPORTS (2015)
Therapeutic targeting of EPH receptors and their ligands
Andrew W. Boyd et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
Jack F. Shern et al.
CANCER DISCOVERY (2014)
Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival
Constantinos Giaginis et al.
BMC CLINICAL PATHOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
Stephen X. Skapek et al.
PEDIATRIC BLOOD & CANCER (2013)
Eph/ephrin signalling during development
Ruediger Klein
DEVELOPMENT (2012)
Cancer Cells Exploit the Eph-Ephrin System to Promote Invasion and Metastasis: Tales of Unwitting Partners
Bingcheng Wang
SCIENCE SIGNALING (2011)
Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
Liang Cao et al.
CANCER RESEARCH (2010)
Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer
Raoul C. Reulen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins
Bernd Wollscheid et al.
NATURE BIOTECHNOLOGY (2009)
R-cadherin expression inhibits myogenesis and induces myoblast transformation via Rac1 GTPase
Jerome Kucharczak et al.
CANCER RESEARCH (2008)
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas
Elai Davicioni et al.
CANCER RESEARCH (2006)
Long-term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study
JA Punyko et al.
PEDIATRIC BLOOD & CANCER (2005)
A statistical model for identifying proteins by tandem mass spectrometry
AI Nesvizhskii et al.
ANALYTICAL CHEMISTRY (2003)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
Share Paper
